Skip to main content
Biocon Gets DCGI Nod for Device to Treat Critical Covid-19 Patients - News18 28-May-2020
Biocon Gets DCGI Nod for Device to Treat Critical Covid-19 Patients - News18
Biocon Biologics, a unit of the company, has got DCGI nod for an extracorporeal blood purification device CytoSorb to reduce pro-inflammatory cytokines levels in confirmed Covid-19 patients admitted to the intensive care unit with confirmed or imminent respir…
More...